Information Provided By:
Fly News Breaks for January 31, 2017
OCRX
Jan 31, 2017 | 08:36 EDT
As noted earlier, JMP Securities downgraded Ocera to Market Perform from Outperform. Analyst Liisa Bayko downgraded the stock based on Phase 2 data which showed that the company's hepatic encephalopathy treatment missed its primary endpoint.
News For OCRX From the Last 2 Days
There are no results for your query OCRX